Related Experiment Video
Updated: Aug 19, 2025

Expression, Purification, and Antimicrobial Activity of S100A12
Published on: May 13, 2017
Pharmacological and Pathological Relevance of S100 Proteins in Neurological Disorders
Deepali Goswami1, Urati Anuradha2, Anok Angati2
1Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, Raebareli, Transit Campus, Bijnour-Sisendi Road, Sarojini Nagar, Lucknow-226002, Uttar Pradesh, India.
Abstract:
The S100 protein is one of the calcium-binding proteins associated with Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis. S100 proteins are expressed in the central nervous system by oligodendrocytes, astrocytes and neurons during both normal and disease conditions. Although amyloid-beta aggregation and hyperphosphorylated tau plaques are the main pathological hallmarks of Alzheimer's disease, the S100 protein family is closely associated with neuroinflammation in several neurodegenerative disorders, such as Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis in addition to various types of cancer and other brain diseases. This review aims to present the key role of S100 proteins and their different relevant isoforms, along with the various approaches used for the regulation of these proteins in several neurodegenerative disorders.

